WFL Share Price Performance
AU$0
0.00 (0.00%)
Sorry, there is currently no price data for this company.
WFL Community Narratives
There are no narratives available yet.
Recent WFL News & Updates
No updates
Wellfully Limited Key Details
Last Reported Earnings
Dec 31, 2022
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.016
- Gross Margin
- -12.05%
- Net Profit Margin
- -469.00%
- Debt/Equity Ratio
- -98.7%
Wellfully Limited Competitors
About WFL
- Founded
- 1992
- Employees
- n/a
- CEO
- WebsiteView website
Wellfully Limited, together with its subsidiaries, focuses on the development and commercialization of Dermaportation and ETP transdermal drug delivery technologies. It operates in two segments, Dermaportation Drug Delivery Technology and Devices. The company is also involved in the industrialization and supply-chain support for its existing product ranges; and sale and marketing of its own brands REDUIT and SWISSWELL, as well as third-party collaborations. It serves the pharmaceutical, cosmetic and skincare, and consumer healthcare sectors. The company was formerly known as OBJ Limited and changed its name to Wellfully Limited in September 2020. Wellfully Limited was incorporated in 1992 and is based in Perth, Australia.
Australian Market Performance
- 7 Days: 1.1%
- 3 Months: 8.3%
- 1 Year: 14.7%
- Year to Date: 7.4%
The market has climbed 1.1% in the last 7 days, lead by the Financials sector with a gain of 1.1%. As for the past 12 months, the market is up 15%. As for the next few years, earnings are expected to grow by 11% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading